A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system

被引:54
作者
Misek, DE
Kuick, R
Wang, H
Galchev, V
Deng, B
Zhao, R
Tra, J
Pisano, MR
Amunugama, R
Allen, D
Walker, AK
Strahler, JR
Andrews, P
Omenn, GS
Hanash, SM
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI USA
[3] PRS Proteom, Ann Arbor, MI USA
[4] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA
关键词
biomarkers; plasma; protein isoforms; proteome profiling; serum;
D O I
10.1002/pmic.200500103
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have implemented an orthogonal 3-D intact protein analysis system (IPAS) to quantitatively profile protein differences between human serum and plasma. Reference specimens consisting of pooled Caucasian-American serum, citrate-anticoagulated plasma, and EDTA-anticoagulated plasma were each depleted of six highly abundant proteins, concentrated, and labeled with a different Cy dye (Cy5, Cy3, or Cy2). A mixture consisting of each of the labeled samples was subjected to three dimensions of separation based on charge, hydrophobicity, and molecular mass. Differences in the abundance of proteins between each of the three samples were determined. More than 5000 bands were found to have greater than two-fold difference in intensity between any pair of labeled specimens by quantitative imaging. As expected, some of the differences in band intensities between serum and plasma were attributable to proteins related to coagulation. Interestingly, many proteins were identified in multiple fractions, each exhibiting different pI, hydrophobicity, or molecular mass. This is likely reflective of the expression of different protein isoforms or specific protein cleavage products, as illustrated by complement component 3 precursor and clusterin. IPAS provides a high resolution, high sensitivity, and quantitative approach for the analysis of serum and plasma proteins, and allows assessment of PTMs as a potential source of biomarkers.
引用
收藏
页码:3343 / 3352
页数:10
相关论文
共 18 条
[1]  
DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708
[2]   GENOMIC ORGANIZATION OF HUMAN-COMPLEMENT COMPONENT-C3 [J].
FONG, KY ;
BOTTO, M ;
WALPORT, MJ ;
SO, AK .
GENOMICS, 1990, 7 (04) :579-586
[3]   Disease proteomics [J].
Hanash, S .
NATURE, 2003, 422 (6928) :226-232
[4]   Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study [J].
He, QY ;
Lau, GKK ;
Zhou, Y ;
Yuen, ST ;
Lin, MC ;
Kung, HF ;
Chiu, JF .
PROTEOMICS, 2003, 3 (05) :666-674
[5]   Molecular studies define the primary structure of α1-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brains -: Comparison of ACT in hippocampus and liver [J].
Hwang, SR ;
Steineckert, B ;
Kohn, A ;
Palkovits, M ;
Hook, VYH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) :1821-1827
[6]   Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction [J].
Marshall, J ;
Kupchak, P ;
Zhu, WM ;
Yantha, J ;
Vrees, T ;
Furesz, S ;
Jacks, K ;
Smith, C ;
Kireeva, I ;
Zhang, R ;
Takahashi, M ;
Stanton, E ;
Jackowski, G .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (04) :361-372
[7]   The Human Proteome Organization Plasma Proteome Project pilot phase: Reference specimens, technology platform comparisons, and standardized data submissions and analyses [J].
Omenn, GS .
PROTEOMICS, 2004, 4 (05) :1235-1240
[8]   Unseen proteome: Mining below the tip of the iceberg to find low abundance and membrane proteins [J].
Pedersen, SK ;
Harry, JL ;
Sebastian, L ;
Baker, J ;
Traini, MD ;
McCarthy, JT ;
Manoharan, A ;
Wilkins, MR ;
Gooley, AA ;
Righetti, PG ;
Packer, NH ;
Williams, KL ;
Herbert, BR .
JOURNAL OF PROTEOME RESEARCH, 2003, 2 (03) :303-311
[9]   Multi-component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome [J].
Pieper, R ;
Su, Q ;
Gatlin, CL ;
Huang, ST ;
Anderson, NL ;
Steiner, S .
PROTEOMICS, 2003, 3 (04) :422-432
[10]   CLUSTERIN - PHYSIOLOGICAL AND PATHOPHYSIOLOGIC CONSIDERATIONS [J].
ROSENBERG, ME ;
SILKENSEN, J .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1995, 27 (07) :633-645